Jagsonpal Pharmaceuticals introduces QueeZy-ER for nausea and vomiting in pregnancy

By on    Pharma Industry News  

Jagsonpal Pharmaceuticals introduces QueeZy-ER for nausea and vomiting in pregnancy

Jagsonpal Pharmaceuticals Limited, a prominent player in the women’s healthcare sector, has introduced QueeZy-ER, aimed at providing relief from Nausea and Vomiting in Pregnancy (NVP). This innovative solution marks a significant advancement in the management of NVP, leveraging the established efficacy of two key ingredients: Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg, in […]

Viatris Inc. announces divestitures in key business sectors: Comprehensive breakdown

By on    Pharma Industry News  

Viatris Inc. announces divestitures in key business sectors: Comprehensive breakdown

Viatris Inc. (NASDAQ: VTRS), a frontrunner in global healthcare, has unveiled a series of divestitures in its business framework. Leading the announcements, Viatris is set to gather gross proceeds of up to $6.94 billion, netting around $5.2 billion after deducting associated costs. Details on Divested Units and Financial Implications: The company’s decision to divest primarily […]